195, route d'Espagne Campus Curie Toulouse, 31036 FranceEvotec is a global leader in drug discovery and development, offering extensive CRO and CDMO services across all stages of the R&D continuum, from target identification to the clinic, delivering efficient, high-quality, and cost-effective solutions. We integrate deep disease understanding, a multimodality approach, advanced technologies and tailored solutions to enhance the probability of success. Our innovative and flexible approach supports collaboration through standalone CRO/CDMO services, integrated drug discovery and development programs, or strategic partnerships, regardless of your stage in the discovery-development journey. Expertise in Modalities and Therapeutic Areas Our broad capabilities cover small molecules, antibodies, antibody drug conjugates, oligonucleotides, peptides, cell therapy, RNA-targeted therapies and other advanced modalities. With particular strength in pharmacology, toxicology, and preclinical formulation, we help de-risk development and optimize the selection of therapeutic candidates. Our consultative approach ensures partners benefit from our deep expertise in complex disease areas, enabling better outcomes from early discovery to clinical development. Innovative R&D Platforms Our AI-powered proprietary R&D platforms, including PanOmics and iPSC technologies, integrate advanced analytics and automation to enhance disease understanding and ensure human relevance. By leveraging continuous manufacturing and high-throughput platforms, we provide faster, more reliable access to high-quality drug candidates, reducing time to clinic and enabling data-driven decision-making. Global Presence and Flexibility Evotec operates globally with an expansive R&D infrastructure, allowing us to offer flexibility in partnering models and scalability in operations. Our state-of-the-art facilities and diverse scientific team of over 4,000 experts are equipped to handle the most complex challenges across therapeutic areas and modalities, including biologics, small molecules, and cell therapies. Driving Impact through Science In an era of rapid innovation, Evotec’s fully integrated drug development solutions position us as a trusted partner for organizations aiming to accelerate their R&D pipelines. Our commitment to scientific excellence, operational flexibility, and deep therapeutic expertise enables us to deliver the highest quality outcomes—from concept to clinical development and beyond. Together, we are creating medicines that matter.

Campus Neuried Anna-Sigmund-Str 5 Neuried, Neuried, 82061 GermanyEvotec is a global leader in drug discovery and development, offering extensive CRO and CDMO services across all stages of the R&D continuum, from target identification to the clinic, delivering efficient, high-quality, and cost-effective solutions. We integrate deep disease understanding, a multimodality approach, advanced technologies and tailored solutions to enhance the probability of success. Our innovative and flexible approach supports collaboration through standalone CRO/CDMO services, integrated drug discovery and development programs, or strategic partnerships, regardless of your stage in the discovery-development journey. Expertise in Modalities and Therapeutic Areas Our broad capabilities cover small molecules, antibodies, antibody drug conjugates, oligonucleotides, peptides, cell therapy, RNA-targeted therapies and other advanced modalities. With particular strength in pharmacology, toxicology, and preclinical formulation, we help de-risk development and optimize the selection of therapeutic candidates. Our consultative approach ensures partners benefit from our deep expertise in complex disease areas, enabling better outcomes from early discovery to clinical development. Innovative R&D Platforms Our AI-powered proprietary R&D platforms, including PanOmics and iPSC technologies, integrate advanced analytics and automation to enhance disease understanding and ensure human relevance. By leveraging continuous manufacturing and high-throughput platforms, we provide faster, more reliable access to high-quality drug candidates, reducing time to clinic and enabling data-driven decision-making. Global Presence and Flexibility Evotec operates globally with an expansive R&D infrastructure, allowing us to offer flexibility in partnering models and scalability in operations. Our state-of-the-art facilities and diverse scientific team of over 4,000 experts are equipped to handle the most complex challenges across therapeutic areas and modalities, including biologics, small molecules, and cell therapies. Driving Impact through Science In an era of rapid innovation, Evotec’s fully integrated drug development solutions position us as a trusted partner for organizations aiming to accelerate their R&D pipelines. Our commitment to scientific excellence, operational flexibility, and deep therapeutic expertise enables us to deliver the highest quality outcomes—from concept to clinical development and beyond. Together, we are creating medicines that matter.

303B College Road East Princeton, NJ, 08540 United StatesEvotec is a global leader in drug discovery and development, offering extensive CRO and CDMO services across all stages of the R&D continuum, from target identification to the clinic, delivering efficient, high-quality, and cost-effective solutions. We integrate deep disease understanding, a multimodality approach, advanced technologies and tailored solutions to enhance the probability of success. Our innovative and flexible approach supports collaboration through standalone CRO/CDMO services, integrated drug discovery and development programs, or strategic partnerships, regardless of your stage in the discovery-development journey. Expertise in Modalities and Therapeutic Areas Our broad capabilities cover small molecules, antibodies, antibody drug conjugates, oligonucleotides, peptides, cell therapy, RNA-targeted therapies and other advanced modalities. With particular strength in pharmacology, toxicology, and preclinical formulation, we help de-risk development and optimize the selection of therapeutic candidates. Our consultative approach ensures partners benefit from our deep expertise in complex disease areas, enabling better outcomes from early discovery to clinical development. Innovative R&D Platforms Our AI-powered proprietary R&D platforms, including PanOmics and iPSC technologies, integrate advanced analytics and automation to enhance disease understanding and ensure human relevance. By leveraging continuous manufacturing and high-throughput platforms, we provide faster, more reliable access to high-quality drug candidates, reducing time to clinic and enabling data-driven decision-making. Global Presence and Flexibility Evotec operates globally with an expansive R&D infrastructure, allowing us to offer flexibility in partnering models and scalability in operations. Our state-of-the-art facilities and diverse scientific team of over 4,000 experts are equipped to handle the most complex challenges across therapeutic areas and modalities, including biologics, small molecules, and cell therapies. Driving Impact through Science In an era of rapid innovation, Evotec’s fully integrated drug development solutions position us as a trusted partner for organizations aiming to accelerate their R&D pipelines. Our commitment to scientific excellence, operational flexibility, and deep therapeutic expertise enables us to deliver the highest quality outcomes—from concept to clinical development and beyond. Together, we are creating medicines that matter.

Campus Neuried Anna-Sigmund-Str. 5 Neuried, 82061 GermanyEvotec is a global leader in drug discovery and development, offering extensive CRO and CDMO services across all stages of the R&D continuum, from target identification to the clinic, delivering efficient, high-quality, and cost-effective solutions. We integrate deep disease understanding, a multimodality approach, advanced technologies and tailored solutions to enhance the probability of success. Our innovative and flexible approach supports collaboration through standalone CRO/CDMO services, integrated drug discovery and development programs, or strategic partnerships, regardless of your stage in the discovery-development journey. Expertise in Modalities and Therapeutic Areas Our broad capabilities cover small molecules, antibodies, antibody drug conjugates, oligonucleotides, peptides, cell therapy, RNA-targeted therapies and other advanced modalities. With particular strength in pharmacology, toxicology, and preclinical formulation, we help de-risk development and optimize the selection of therapeutic candidates. Our consultative approach ensures partners benefit from our deep expertise in complex disease areas, enabling better outcomes from early discovery to clinical development. Innovative R&D Platforms Our AI-powered proprietary R&D platforms, including PanOmics and iPSC technologies, integrate advanced analytics and automation to enhance disease understanding and ensure human relevance. By leveraging continuous manufacturing and high-throughput platforms, we provide faster, more reliable access to high-quality drug candidates, reducing time to clinic and enabling data-driven decision-making. Global Presence and Flexibility Evotec operates globally with an expansive R&D infrastructure, allowing us to offer flexibility in partnering models and scalability in operations. Our state-of-the-art facilities and diverse scientific team of over 4,000 experts are equipped to handle the most complex challenges across therapeutic areas and modalities, including biologics, small molecules, and cell therapies. Driving Impact through Science In an era of rapid innovation, Evotec’s fully integrated drug development solutions position us as a trusted partner for organizations aiming to accelerate their R&D pipelines. Our commitment to scientific excellence, operational flexibility, and deep therapeutic expertise enables us to deliver the highest quality outcomes—from concept to clinical development and beyond. Together, we are creating medicines that matter.

Hamburg, HH GermanyEvotec is a global leader in drug discovery and development, offering extensive CRO and CDMO services across all stages of the R&D continuum, from target identification to the clinic, delivering efficient, high-quality, and cost-effective solutions. We integrate deep disease understanding, a multimodality approach, advanced technologies and tailored solutions to enhance the probability of success. Our innovative and flexible approach supports collaboration through standalone CRO/CDMO services, integrated drug discovery and development programs, or strategic partnerships, regardless of your stage in the discovery-development journey. Expertise in Modalities and Therapeutic Areas Our broad capabilities cover small molecules, antibodies, antibody drug conjugates, oligonucleotides, peptides, cell therapy, RNA-targeted therapies and other advanced modalities. With particular strength in pharmacology, toxicology, and preclinical formulation, we help de-risk development and optimize the selection of therapeutic candidates. Our consultative approach ensures partners benefit from our deep expertise in complex disease areas, enabling better outcomes from early discovery to clinical development. Innovative R&D Platforms Our AI-powered proprietary R&D platforms, including PanOmics and iPSC technologies, integrate advanced analytics and automation to enhance disease understanding and ensure human relevance. By leveraging continuous manufacturing and high-throughput platforms, we provide faster, more reliable access to high-quality drug candidates, reducing time to clinic and enabling data-driven decision-making. Global Presence and Flexibility Evotec operates globally with an expansive R&D infrastructure, allowing us to offer flexibility in partnering models and scalability in operations. Our state-of-the-art facilities and diverse scientific team of over 4,000 experts are equipped to handle the most complex challenges across therapeutic areas and modalities, including biologics, small molecules, and cell therapies. Driving Impact through Science In an era of rapid innovation, Evotec’s fully integrated drug development solutions position us as a trusted partner for organizations aiming to accelerate their R&D pipelines. Our commitment to scientific excellence, operational flexibility, and deep therapeutic expertise enables us to deliver the highest quality outcomes—from concept to clinical development and beyond. Together, we are creating medicines that matter.

via A. Fleming, 4 Campus Levi Montalcini Verona, 37135 ItalyEvotec is a global leader in drug discovery and development, offering extensive CRO and CDMO services across all stages of the R&D continuum, from target identification to the clinic, delivering efficient, high-quality, and cost-effective solutions. We integrate deep disease understanding, a multimodality approach, advanced technologies and tailored solutions to enhance the probability of success. Our innovative and flexible approach supports collaboration through standalone CRO/CDMO services, integrated drug discovery and development programs, or strategic partnerships, regardless of your stage in the discovery-development journey. Expertise in Modalities and Therapeutic Areas Our broad capabilities cover small molecules, antibodies, antibody drug conjugates, oligonucleotides, peptides, cell therapy, RNA-targeted therapies and other advanced modalities. With particular strength in pharmacology, toxicology, and preclinical formulation, we help de-risk development and optimize the selection of therapeutic candidates. Our consultative approach ensures partners benefit from our deep expertise in complex disease areas, enabling better outcomes from early discovery to clinical development. Innovative R&D Platforms Our AI-powered proprietary R&D platforms, including PanOmics and iPSC technologies, integrate advanced analytics and automation to enhance disease understanding and ensure human relevance. By leveraging continuous manufacturing and high-throughput platforms, we provide faster, more reliable access to high-quality drug candidates, reducing time to clinic and enabling data-driven decision-making. Global Presence and Flexibility Evotec operates globally with an expansive R&D infrastructure, allowing us to offer flexibility in partnering models and scalability in operations. Our state-of-the-art facilities and diverse scientific team of over 4,000 experts are equipped to handle the most complex challenges across therapeutic areas and modalities, including biologics, small molecules, and cell therapies. Driving Impact through Science In an era of rapid innovation, Evotec’s fully integrated drug development solutions position us as a trusted partner for organizations aiming to accelerate their R&D pipelines. Our commitment to scientific excellence, operational flexibility, and deep therapeutic expertise enables us to deliver the highest quality outcomes—from concept to clinical development and beyond. Together, we are creating medicines that matter.

Essener Bogen 7 Manfred Eigen Campus Hamburg, Hamburg, 22419 GermanyEvotec is a global leader in drug discovery and development, offering extensive CRO and CDMO services across all stages of the R&D continuum, from target identification to the clinic, delivering efficient, high-quality, and cost-effective solutions. We integrate deep disease understanding, a multimodality approach, advanced technologies and tailored solutions to enhance the probability of success. Our innovative and flexible approach supports collaboration through standalone CRO/CDMO services, integrated drug discovery and development programs, or strategic partnerships, regardless of your stage in the discovery-development journey. Expertise in Modalities and Therapeutic Areas Our broad capabilities cover small molecules, antibodies, antibody drug conjugates, oligonucleotides, peptides, cell therapy, RNA-targeted therapies and other advanced modalities. With particular strength in pharmacology, toxicology, and preclinical formulation, we help de-risk development and optimize the selection of therapeutic candidates. Our consultative approach ensures partners benefit from our deep expertise in complex disease areas, enabling better outcomes from early discovery to clinical development. Innovative R&D Platforms Our AI-powered proprietary R&D platforms, including PanOmics and iPSC technologies, integrate advanced analytics and automation to enhance disease understanding and ensure human relevance. By leveraging continuous manufacturing and high-throughput platforms, we provide faster, more reliable access to high-quality drug candidates, reducing time to clinic and enabling data-driven decision-making. Global Presence and Flexibility Evotec operates globally with an expansive R&D infrastructure, allowing us to offer flexibility in partnering models and scalability in operations. Our state-of-the-art facilities and diverse scientific team of over 4,000 experts are equipped to handle the most complex challenges across therapeutic areas and modalities, including biologics, small molecules, and cell therapies. Driving Impact through Science In an era of rapid innovation, Evotec’s fully integrated drug development solutions position us as a trusted partner for organizations aiming to accelerate their R&D pipelines. Our commitment to scientific excellence, operational flexibility, and deep therapeutic expertise enables us to deliver the highest quality outcomes—from concept to clinical development and beyond. Together, we are creating medicines that matter.

111 Innovation Drive Milton Park Abingdon, Oxfordshire, OX14 4RZ United KingdomEvotec is a global leader in drug discovery and development, offering extensive CRO and CDMO services across all stages of the R&D continuum, from target identification to the clinic, delivering efficient, high-quality, and cost-effective solutions. We integrate deep disease understanding, a multimodality approach, advanced technologies and tailored solutions to enhance the probability of success. Our innovative and flexible approach supports collaboration through standalone CRO/CDMO services, integrated drug discovery and development programs, or strategic partnerships, regardless of your stage in the discovery-development journey. Expertise in Modalities and Therapeutic Areas Our broad capabilities cover small molecules, antibodies, antibody drug conjugates, oligonucleotides, peptides, cell therapy, RNA-targeted therapies and other advanced modalities. With particular strength in pharmacology, toxicology, and preclinical formulation, we help de-risk development and optimize the selection of therapeutic candidates. Our consultative approach ensures partners benefit from our deep expertise in complex disease areas, enabling better outcomes from early discovery to clinical development. Innovative R&D Platforms Our AI-powered proprietary R&D platforms, including PanOmics and iPSC technologies, integrate advanced analytics and automation to enhance disease understanding and ensure human relevance. By leveraging continuous manufacturing and high-throughput platforms, we provide faster, more reliable access to high-quality drug candidates, reducing time to clinic and enabling data-driven decision-making. Global Presence and Flexibility Evotec operates globally with an expansive R&D infrastructure, allowing us to offer flexibility in partnering models and scalability in operations. Our state-of-the-art facilities and diverse scientific team of over 4,000 experts are equipped to handle the most complex challenges across therapeutic areas and modalities, including biologics, small molecules, and cell therapies. Driving Impact through Science In an era of rapid innovation, Evotec’s fully integrated drug development solutions position us as a trusted partner for organizations aiming to accelerate their R&D pipelines. Our commitment to scientific excellence, operational flexibility, and deep therapeutic expertise enables us to deliver the highest quality outcomes—from concept to clinical development and beyond. Together, we are creating medicines that matter.

303B College Road East Princeton, NJ, 08540 United States Minor Outlying IslandsEvotec is a global leader in drug discovery and development, offering extensive CRO and CDMO services across all stages of the R&D continuum, from target identification to the clinic, delivering efficient, high-quality, and cost-effective solutions. We integrate deep disease understanding, a multimodality approach, advanced technologies and tailored solutions to enhance the probability of success. Our innovative and flexible approach supports collaboration through standalone CRO/CDMO services, integrated drug discovery and development programs, or strategic partnerships, regardless of your stage in the discovery-development journey. Expertise in Modalities and Therapeutic Areas Our broad capabilities cover small molecules, antibodies, antibody drug conjugates, oligonucleotides, peptides, cell therapy, RNA-targeted therapies and other advanced modalities. With particular strength in pharmacology, toxicology, and preclinical formulation, we help de-risk development and optimize the selection of therapeutic candidates. Our consultative approach ensures partners benefit from our deep expertise in complex disease areas, enabling better outcomes from early discovery to clinical development. Innovative R&D Platforms Our AI-powered proprietary R&D platforms, including PanOmics and iPSC technologies, integrate advanced analytics and automation to enhance disease understanding and ensure human relevance. By leveraging continuous manufacturing and high-throughput platforms, we provide faster, more reliable access to high-quality drug candidates, reducing time to clinic and enabling data-driven decision-making. Global Presence and Flexibility Evotec operates globally with an expansive R&D infrastructure, allowing us to offer flexibility in partnering models and scalability in operations. Our state-of-the-art facilities and diverse scientific team of over 4,000 experts are equipped to handle the most complex challenges across therapeutic areas and modalities, including biologics, small molecules, and cell therapies. Driving Impact through Science In an era of rapid innovation, Evotec’s fully integrated drug development solutions position us as a trusted partner for organizations aiming to accelerate their R&D pipelines. Our commitment to scientific excellence, operational flexibility, and deep therapeutic expertise enables us to deliver the highest quality outcomes—from concept to clinical development and beyond. Together, we are creating medicines that matter.